Company intelligence
AB-BIOTICS
Bringing probiotics to life, AB-BIOTICS leads the market with innovative solutions. Agile, science-driven, and worldwide
About AB-BIOTICS
AB-BIOTICS is a leading probiotics player inspired by developing probiotic solutions at the forefront of an expanding field. Whether you are interested in unique, patented strains with characterized mechanisms of action, premium probiotic solutions targeting specific therapeutic areas, or finished products with easily-communicated benefits, our agile approach allows us to adapt to your needs. With science at the heart of everything we do, our strains, blends and market-ready products are supported by robust scientific documentation. Our global footprint gives us a unique view of the ever-changing probiotic landscape enabling us to offer regulatory support in not only supplements, and functional foods but also OTC and medical applications to meet the needs of consumers worldwide.
Verified activity
Signals from AB-BIOTICS
4 published signals
Presence & Recognition
AB-BIOTICS colleague Núria Gispets Parés presented a poster on a post-hoc analysis of the latest clinical trial on Gyntima Menopause at the ESPEN European Society for Clinical Nutrition and Metabolism Congress in Berlin.
Reported by AB-BIOTICS
Presence & Recognition
AB-BIOTICS announced that Vitafoods Asia 2026 has concluded with a booth in Bangkok.
Reported by AB-BIOTICS
Presence & Recognition
AB-BIOTICS participated in the Longevity Innovation Tour at Vitafoods Asia 2026, stopping by Booth H6-K42 to showcase science-backed solutions for healthy ageing.
Reported by AB-BIOTICS
Presence & Recognition
AB-BIOTICS Gyntima Menopause has been selected as a finalist at the NutraIngredients Asia Awards in the Ingredient of the Year: Microbiome Modulator category.
Reported by AB-BIOTICS